Circulating extracellular vesicles containing miRNAs may have utility as early biomarkers for cardiac injury

Annals of Translational Medicine

Volumn 4, Issue , 2016, Pages

  Doran, Bethany ^a   Voora, Deepak ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE MB; MICRORNA; TROPONIN; BIOLOGICAL MARKER; MICRORNA 1; MICRORNA 146A; MICRORNA 208; MICRORNA 21; MICRORNA 499; UNCLASSIFIED DRUG;

COLON CANCER; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; EXERCISE TEST; EXOSOME; GENE EXPRESSION; GOLD STANDARD; HEART INFARCTION; HEART INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEPATITIS C; HUMAN; MORBIDITY; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; NONHUMAN; NOTE; PHYSIOLOGICAL PROCESS; PROGNOSIS; RNA ANALYSIS; RNA DEGRADATION; SENSITIVITY AND SPECIFICITY; SYMPTOM; DISEASE ASSOCIATION; DISEASE BURDEN;

EID: 85011339606     PISSN: 23055839     EISSN: 23055847     Source Type: Journal    
DOI: 10.21037/atm.2016.10.55     Document Type: Note

References (16)

1. Sugiyama T, Hasegawa K, Kobayashi Y, et al. Differential time trends of outcomes and costs of care for acute myocardial infarction hospitalizations by ST elevation and type of intervention in the United States, 2001-2011. J Am Heart Assoc 2015;4:e001445.
2. Keller T, Zeller T, Peetz D, et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009;361:868-77.
3. Forberg JL, Henriksen LS, Edenbrandt L, et al. Direct hospital costs of chest pain patients attending the emergency department: a retrospective study. BMC Emerg Med 2006;6:6.
4. Task Force for Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of European Society of Cardiology, Bassand JP, Hamm CW, Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 2007;28:1598-660.
5. Antman EM, Hand M, Armstrong PW, et al. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee. Circulation 2008;117:296-329.
6. Thygesen K, Alpert JS, White HD, et al. Universal definition of myocardial infarction. Circulation 2007;116:2634-53.
7. Deddens JC, Vrijsen KR, Colijn JM, et al. Circulating Extracellular Vesicles Contain miRNAs and are Released as Early Biomarkers for Cardiac Injury. J Cardiovasc Transl Res 2016;9:291-301.
8. Li Z, Rana TM. Therapeutic targeting of microRNAs: current status and future challenges. Nat Rev Drug Discov 2014;13:622-38.
9. Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay.Nat Rev Genet 2010;11:597-610.
10. Ren XP, Wu J, Wang X, et al. MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20. Circulation 2009;119:2357-66.
11. Ji X, Takahashi R, Hiura Y, et al. Plasma miR-208 as a biomarker of myocardial injury. Clin Chem 2009;55:1944-9.
12. Wang X, Zhang X, Ren XP, et al. MicroRNA-494 targeting both proapoptotic and antiapoptotic proteins protects against ischemia/reperfusion-induced cardiac injury. Circulation 2010;122:1308-18.
13. van Rooij E, Purcell AL, Levin AA. Developing microRNA therapeutics. Circ Res 2012;110:496-507.
14. Boulanger CM, Scoazec A, Ebrahimian T, et al. Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 2001;104:2649-52.
15. Lanford RE, Hildebrandt-Eriksen ES, Petri A, et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 2010;327:198-201.
16. Huang JL, Urtatiz O, Van Raamsdonk CD. Oncogenic G Protein GNAQ Induces Uveal Melanoma and Intravasation in Mice. Cancer Res 2015;75:3384-97.